Quick Answer
Bausch Health Companies Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $10.27 billion for the year ending 2025.
- Bausch Health Companies Inc. showed an increase of +6.7% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from Bausch Health Companies Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $2.11 billion | Q2 2017: $2.23 billion | Q3 2017: $2.22 billion | Q4 2017: $2.16 billion | Q1 2018: $2.00 billion | Q2 2018: $2.13 billion | Q3 2018: $2.14 billion | Q4 2018: $2.12 billion | Q1 2019: $2.02 billion | Q2 2019: $2.15 billion | Q3 2019: $2.21 billion | Q4 2019: $2.22 billion | Q1 2020: $2.01 billion | Q2 2020: $1.66 billion | Q3 2020: $2.14 billion | Q4 2020: $2.21 billion | Q1 2021: $2.03 billion | Q2 2021: $2.10 billion | Q3 2021: $2.11 billion | Q1 2022: $1.92 billion | Q2 2022: $1.97 billion | Q3 2022: $2.05 billion | Q1 2023: $1.94 billion | Q2 2023: $2.17 billion | Q3 2023: $2.24 billion | Q1 2024: $2.15 billion | Q2 2024: $2.40 billion | Q3 2024: $2.51 billion | Q1 2025: $2.26 billion | Q2 2025: $2.53 billion | Q3 2025: $2.68 billion.
- Over the full 10 years of available data (2016 to 2025), Bausch Health Companies Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 6.1%.
- Historical annual values: Fiscal year 2025: $10.27 billion | Fiscal year 2024: $9.63 billion | Fiscal year 2023: $8.76 billion | Fiscal year 2022: $8.12 billion | Fiscal year 2021: $8.43 billion | Fiscal year 2020: $8.03 billion | Fiscal year 2019: $8.60 billion | Fiscal year 2018: $8.38 billion | Fiscal year 2017: $8.72 billion | Fiscal year 2016: $9.67 billion.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: